Detalhe da pesquisa
1.
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Breast Cancer Res Treat
; 169(3): 537-548, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29455298
2.
The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).
J Support Oncol
; 9(1): 24-31, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21399726
3.
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412.
J Clin Oncol
; 39(12): 1329-1338, 2021 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33555941